Murata T - Search Results

1

[The development of methods to evaluate experimental animal behavior using images].

Sakamoto N, Miyazaki Y, Kobayashi K, Minato T, Murata T. Sakamoto N, et al. Among authors: murata t. Nihon Yakurigaku Zasshi. 2023;158(2):182-186. doi: 10.1254/fpj.22126. Nihon Yakurigaku Zasshi. 2023. PMID: 36858503 Review. Japanese.

2

[The role of bioactive lipid mediators in nasal congestion of allergic rhinitis].

Ozaki N, Sakamoto N, Murata T. Ozaki N, et al. Among authors: murata t. Nihon Yakurigaku Zasshi. 2024;159(3):182. doi: 10.1254/fpj.24004. Nihon Yakurigaku Zasshi. 2024. PMID: 38692884 Review. Japanese. No abstract available.

3

[The effect of bioactive substances derived from gut bacteria on the development of allergic diseases].

Yamamoto S, Murata T. Yamamoto S, et al. Among authors: murata t. Nihon Yakurigaku Zasshi. 2022;157(1):85. doi: 10.1254/fpj.21088. Nihon Yakurigaku Zasshi. 2022. PMID: 34980817 Japanese. No abstract available.

4

[In vitro and in vivo angiogenesis assays].

Murata T. Murata T. Nihon Yakurigaku Zasshi. 2009 May;133(5):261-5. doi: 10.1254/fpj.133.261. Nihon Yakurigaku Zasshi. 2009. PMID: 19443962 Review. Japanese. No abstract available.

5

[How does dysbiosis cause allergic diseases?].

Suzuki K, Murata T. Suzuki K, et al. Among authors: murata t. Nihon Yakurigaku Zasshi. 2023;158(1):102. doi: 10.1254/fpj.22113. Nihon Yakurigaku Zasshi. 2023. PMID: 36596478 Japanese. No abstract available.

6

[Discovery of anti-inflammatory role of prostaglandin D₂].

Murata T. Murata T. Nihon Yakurigaku Zasshi. 2015 Oct;146(4):201-7. doi: 10.1254/fpj.146.201. Nihon Yakurigaku Zasshi. 2015. PMID: 26656964 Review. Japanese. No abstract available.

7

Effective treatment of topical corticosteroid-resistant dermatitis with delgocitinib in a pediatric patient with Netherton syndrome.

Teraoka M, Yonekura S, Takegami T, Murata T, Egawa G, Nakajima S, Kabashima K. Teraoka M, et al. Among authors: murata t. J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17311. Online ahead of print. J Dermatol. 2024. PMID: 38804630 No abstract available.

8

Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.

RECAP study group; Tsukamoto S, Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, Machimura H, Shimura H, Wakui H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Muta Y, Takashi Y, Tamura K. RECAP study group, et al. Among authors: murata t. Diabetes Obes Metab. 2024 May 19. doi: 10.1111/dom.15652. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38764356

9

Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.

Shiroiwa T, King MT, Norman R, Müller F, Campbell R, Kemmler G, Murata T, Shimozuma K, Fukuda T. Shiroiwa T, et al. Among authors: murata t. Qual Life Res. 2024 May 9. doi: 10.1007/s11136-024-03655-7. Online ahead of print. Qual Life Res. 2024. PMID: 38724771

10

Skeletal Formation of Carbocycles with CO₂: Selective Synthesis of Indolo[3,2-b]carbazoles or Cyclophanes from Indoles, CO₂, and Phenylsilane.

Li S, Nakahara S, Adachi T, Murata T, Takaishi K, Ema T. Li S, et al. Among authors: murata t. J Am Chem Soc. 2024 May 9. doi: 10.1021/jacs.4c04097. Online ahead of print. J Am Chem Soc. 2024. PMID: 38722086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,768 results

Search Page